The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases. Kim H, Alten R, Avedano L, Dignass A, et al. Drugs 2020;80:99-113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim H, Alten R, Avedano L, Dignass A, et al. The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases. Drugs 2020;80:99-113.
PMID: 32002851